Skip to content

Candesartan Cilexetil EP Impurity C

Candesartan Cilexetil EP Impurity C

Product Description
CAT No.
ALN-C011004
CAS No.
1185255-99-5
Mol. F.
C33H34N6O6
Mol. Wt.
610.7
Stock
In Stock
RFQ
Chemical Name : (1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2′-(1-ethyl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate ;
Smiles : O=C(OC(C)OC(OC1CCCCC1)=O)C2=CC=CC(NC3=O)=C2N3CC(C=C4)=CC=C4C5=CC=CC=C5C6=NN=NN6CC
Inchi : InChI=1S/C31H30N6O6/c1-19(42-31(40)43-22-8-3-2-4-9-22)41-29(38)25-12-7-13-26-27(25)37(30(39)32-26)18-20-14-16-21(17-15-20)23-10-5-6-11-24(23)28-33-35-36-34-28/h5-7,10-17,19,22H,2-4,8-9,18H2,1H3,(H,32,39)(H,33,34,35,36)/t19-/m1/s1
Synonym : Candesartan Cilexetil N1-Ethyl Amide ; Candesartan Cilexetil O-Desethyl N1-Ethyl Impurity ; 2-Desethoxy-2-Hydroxy-1H-N1-Ethyl Candesartan Cilexetil ;

Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR

Bhanu Ramana,u2217, Brajesh A. Sharmaa,b, Ganesh Mahale b, Dharmendra Singhb, Ashok KumarnJournal of Pharmaceutical and Biomedical Analysis 56 (2011) 256u2013263

Synergistic suppression of tumor angiogenesis by codelivering of VEGF targeted siRNA and candesartan mediated by functionalized carbon nanovectors

Xuefang Ding, Yujie Su, Cheng Wang, Fangrong Zhang, Kerong Chen, Yu Wang, Min Li, and Wei Wang – ACS Appl. Mater. Interfaces 2017, 9, 28, 23353–23369

Identification, Isolation, and Characterization of Five Potential Degradation Impurities in Candesartan Cilexetil Tablets

Arivozhi Mohan1,&, S. Shanmugavel1 , Ajay Goyal1 , B. R. Venkataraman2 , D. Saravanan – Chromatographia volume 69, pages1211–1220(2009)

Request For Quotation

Related Products